Vanda Pharmaceuticals Inc. - Common Stock (VNDA)
Frequently Asked Questions About Vanda Pharmaceuticals Inc. - Common Stock (VNDA)
Has Vanda Pharmaceuticals received any regulatory approvals?
Yes, Vanda Pharmaceuticals has received regulatory approvals from the U.S. Food and Drug Administration (FDA) for its key products, including Hetlioz and Fanapt. These approvals signify the company's compliance with safety and efficacy standards required for marketing its therapeutics.
How can investors contact Vanda Pharmaceuticals?
Investors can contact Vanda Pharmaceuticals through the investor relations section of their official website. They can also reach out via email or phone for inquiries related to stock performance, upcoming investor events, and financial reports.
How does Vanda Pharmaceuticals approach drug development?
Vanda Pharmaceuticals employs a patient-centric approach to drug development, focusing on identifying and addressing significant unmet medical needs in CNS disorders. The company utilizes both rigorous clinical research and pharmacological expertise to ensure its therapies are safe and effective for patients.
How does Vanda Pharmaceuticals support patients and healthcare providers?
Vanda Pharmaceuticals supports patients and healthcare providers through educational resources, detailed prescribing information, and dedicated support programs. These initiatives aim to ensure that patients have access to necessary therapies and understand their treatment options.
Is Vanda Pharmaceuticals involved in any partnerships?
Yes, Vanda Pharmaceuticals has established collaborations with academic institutions and research organizations to further its drug development efforts. These partnerships help leverage external expertise and resources in the pursuit of new treatment options for patients.
Is Vanda Pharmaceuticals publicly traded?
Yes, Vanda Pharmaceuticals Inc. is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol VNDA. Investors can buy and sell shares of the company through various stock brokerage platforms.
What are some key products offered by Vanda Pharmaceuticals?
Vanda Pharmaceuticals has several key products, including Fanapt (iloperidone), indicated for the treatment of schizophrenia, and Hetlioz (tasimelteon), which is used for the treatment of non-24-hour sleep-wake disorder. These products demonstrate the company's commitment to addressing specific patient needs within CNS therapeutics.
What are the latest developments from Vanda Pharmaceuticals?
As of 2023, Vanda Pharmaceuticals has been engaged in clinical trials for new indications and formulations of its existing drugs, as well as exploring new therapies for CNS disorders. They routinely update their pipeline and research findings through press releases and investor presentations.
What are the target markets for Vanda Pharmaceuticals?
Vanda Pharmaceuticals primarily targets the markets for psychiatric and sleep disorders. By focusing on these specific segments, the company aims to develop innovative solutions that improve the quality of life for patients living with complex CNS conditions.
What does Vanda Pharmaceuticals Inc. do?
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies to address unmet medical needs in the treatment of central nervous system (CNS) disorders. The company specializes in developing drugs for conditions like schizophrenia, sleep disorders, and other related CNS issues.
What is Fanapt, and what conditions does it treat?
Fanapt (iloperidone) is an atypical antipsychotic medication developed by Vanda Pharmaceuticals for the treatment of schizophrenia in adults. It works by affecting various neurotransmitter receptors in the brain, helping to alleviate symptoms associated with this mental health condition.
What is Hetlioz and what is it used for?
Hetlioz (tasimelteon) is a prescription medication developed by Vanda Pharmaceuticals specifically for the treatment of non-24-hour sleep-wake disorder, a condition that affects individuals who are totally blind. It helps regulate sleep patterns by acting on melatonin receptors.
What is the company’s financial performance like?
Vanda Pharmaceuticals’ financial performance varies based on product sales, research and development costs, and overall market conditions. Investors can review the company's quarterly and annual financial reports to gain insights into revenue, profitability, and operational expenditures.
What is Vanda's commitment to clinical trials?
Vanda Pharmaceuticals is strongly committed to conducting rigorous clinical trials to evaluate the safety and efficacy of its products. The company follows ethical research practices and regulatory requirements to ensure the well-being of participants and the integrity of the data collected.
What is Vanda's mission statement?
Vanda Pharmaceuticals' mission is to improve patient health and quality of life through the development of innovative pharmaceuticals that address unmet medical needs. The company is committed to advancing science and delivering meaningful therapies to the patient population.
What is Vanda's research focus?
Vanda Pharmaceuticals focuses its research efforts on the central nervous system, particularly in areas related to schizophrenia, sleep disorders, and other psychiatric conditions. The company invests in discovering and developing new compounds that can offer improved treatment options for patients.
When was Vanda Pharmaceuticals Inc. founded?
Vanda Pharmaceuticals Inc. was founded in 2003. Since its inception, the company has been dedicated to advancing new treatments for mental health and sleep disorders through its focused research and development efforts.
Where is Vanda Pharmaceuticals headquartered?
Vanda Pharmaceuticals is headquartered in Washington, D.C. This strategic location enables the company to stay connected with regulatory bodies, industry partners, and academic institutions essential for its operations and advancements in drug development.
Who are Vanda Pharmaceuticals' competitors?
Vanda Pharmaceuticals faces competition from several biotechnology and pharmaceutical companies involved in CNS therapeutics, such as Eli Lilly and Company, Otsuka Pharmaceutical, and Jazz Pharmaceuticals. These companies also focus on innovative treatments for schizophrenia and sleep disorders.
What is the current price of Vanda Pharmaceuticals Inc. - Common Stock?
The current price of Vanda Pharmaceuticals Inc. - Common Stock is 4.155
When was Vanda Pharmaceuticals Inc. - Common Stock last traded?
The last trade of Vanda Pharmaceuticals Inc. - Common Stock was at 2:55 pm EDT on April 4th, 2025
What is the market capitalization of Vanda Pharmaceuticals Inc. - Common Stock?
The market capitalization of Vanda Pharmaceuticals Inc. - Common Stock is 231.18M
How many shares of Vanda Pharmaceuticals Inc. - Common Stock are outstanding?
Vanda Pharmaceuticals Inc. - Common Stock has 55.64M shares outstanding.